TGFβ Promotes Genomic Instability after Loss of RUNX3

Vaidehi Krishnan1, Yu Lin Chong2, Tuan Zea Tan2

  • 1Cancer Science Institute of Singapore, National University of Singapore, Singapore. csiitoy@nus.edu.sg bchtjp@nus.edu.sg csivk@nus.edu.sg.

Cancer Research
|October 28, 2017
PubMed

Insights

RUNX3 loss in cancer cells removes an antioxidant defense, allowing TGFβ from the tumor microenvironment to induce DNA damage and genomic instability, promoting tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genomic instability research has historically overlooked extrinsic factors in the tumor microenvironment (TME).
  • Transforming growth factor beta (TGFβ) is a key TME cytokine driving cancer aggressiveness, including invasion, drug resistance, and epithelial-to-mesenchymal transition (EMT).

Purpose of the Study:

  • To investigate the role of TGFβ in promoting genomic instability within the TME.
  • To elucidate the mechanism by which RUNX3 loss influences TGFβ-induced DNA damage and cancer progression.

Main Methods:

  • Analysis of DNA double-strand breaks (DSB) in cancer cells with and without RUNX3.
  • Assessment of heme oxygenase-1 (HO-1/HMOX1) expression and its role as a redox regulator.
  • Evaluation of oxidative DNA damage, cellular senescence, and senescence-associated secretory phenotype (SASP) markers.
  • Correlation of TGFβ gene expression signatures and RUNX3 loss with genomic instability in tumors.

Main Results:

  • TGFβ induces DNA double-strand breaks (DSB) in cancer cells lacking the RUNX3 tumor suppressor.
  • RUNX3 loss leads to reduced heme oxygenase-1 (HO-1) expression, impairing the antioxidant response.
  • Elevated oxidative DNA damage triggers cellular senescence and the pro-tumorigenic senescence-associated secretory phenotype (SASP).
  • Tumors with both TGFβ signatures and RUNX3 loss exhibit significantly higher genomic instability.

Conclusions:

  • RUNX3 acts as a critical barrier against TGFβ-driven genomic instability and tumor progression.
  • RUNX3 inactivation cooperates with extrinsic TGFβ signaling to exacerbate genomic instability in cancer.
  • Restoring RUNX3 function may represent a therapeutic strategy to counteract TGFβ-induced DNA damage in the TME.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K